Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus

OBJECTIVE: Fas/Fas ligand (FasL) and B cell-activating factor (BAFF) signalling have pivotal roles in SLE pathogenesis. We investigated the clinical associations of serum concentrations of soluble Fas (sFas) and soluble FasL (sFasL) in SLE and their relationship with BAFF. METHODS: Serum sFas and sF...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Lupus Sci Med
Auteurs principaux: Vincent, Fabien B, Kandane-Rathnayake, Rangi, Koelmeyer, Rachel, Harris, James, Hoi, Alberta Y, Mackay, Fabienne, Morand, Eric F
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2020
Sujets:
Biomarker Studies
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7299016/
https://ncbi.nlm.nih.gov/pubmed/32546562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2019-000375
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires